Cadrenal Therapeutics, Inc. (CVKD) stock
CVKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/30
$1.72−0.16 (-8.51%)
Close on Nov 18, 2026Market cap $6.14MP/E –Yield 959.30%
Cadrenal Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cadrenal Therapeutics's enterprise value was $2.10M on Nov 11, 2026, against $15.48M a year earlier. Over the last 4 years it ranged from -$3.12M to $23.85M, with a median of $10.11M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.10M | -79.2% |
| 2025 | Dec 31, 2025 | $10.11M | -25.3% |
| 2024 | Dec 31, 2024 | $13.53M | +2473.7% |
| 2023 | Dec 29, 2023 | $525.57K | – |
See a number that looks wrong?